![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Doravirine Resistance Profile in Clinical Isolates and Impact of Baseline NNRTI Resistance-Associated Mutations Observed in Treatment-Naïve Participants from Phase 2 and 3 Clinical Trials
|
|
|
Ernest Asante-Appiah1; Johnny Lai2; Qing Li1; DongmeiYang2; Elizabeth Anne Martin1; Peter Sklar1; Daria Hazuda1; Christos J. Petropoulos2; Charles Walworth2; Jay A. Grobler1
1Merck & Co., Inc., Kenilworth, NJ, USA. 2Monogram Biosciences, South San Francisco, CA, USA
23rd International AIDS Conference (AIDS 2020: Virtual), July 6-10, 2020.
Reported by Jules Levin
![0713201](../images/071520/071420-8/0713201.gif)
![0713202](../images/071520/071420-8/0713202.gif)
![0713203](../images/071520/071420-8/0713203.gif)
![0713204](../images/071520/071420-8/0713204.gif)
![0713205](../images/071520/071420-8/0713205.gif)
![0713206](../images/071520/071420-8/0713206.gif)
![0713207](../images/071520/071420-8/0713207.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|